earnings

Big Biotech Set for Earnings Blowout?
Big Biotech Set for Earnings Blowout?
Barron's
biotech
earnings
Gilead Sciences
Alexion
Vertex Pharmaceuticals
Flag link:
Medtronic releases long term guidance
Medtronic releases long term guidance
Mass Device
Medtronic
devices
guidance
earnings
Flag link:
AstraZeneca blames earnings nick on cost of biologics plant in Sweden
AstraZeneca blames earnings nick on cost of biologics plant in Sweden
Fierce Pharma
AstraZeneca
drug manufacturing
earnings
Sweden
Flag link:
Medtronic Gets Huge Surge in Sales from Diabetes and Valves
Medtronic Gets Huge Surge in Sales from Diabetes and Valves
Medical Devices and Diagnostics Industry
Medtronic
devices
earnings
Flag link:
The health care industry is awash in cash
The health care industry is awash in cash
Axios
cash
earnings
Flag link:
Another disappointing quarter for AstraZeneca, shares drop 2%
Another disappointing quarter for AstraZeneca, shares drop 2%
GoinPharma
AstraZeneca
earnings
Flag link:
Forget Cara Therapeutics' Earnings -- Here's the Real News
Forget Cara Therapeutics' Earnings -- Here's the Real News
Motley Fool
earnings
Cara Therapeutics
Korsuva
Flag link:
Momenta Pharmaceuticals Contemplates Its Future
Momenta Pharmaceuticals Contemplates Its Future
Motley Fool
Momenta Pharmaceuticals
earnings
Flag link:
AstraZeneca’s 1Q18 Earnings: Analysts' Estimates
AstraZeneca’s 1Q18 Earnings: Analysts' Estimates
Market Realist
AstraZeneca
earnings
Flag link:
Celgene Starts the Year With a Bang
Celgene Starts the Year With a Bang
Motley Fool
Celgene
earnings
Flag link:
Puma shares plummet as results from key trial delayed
Puma shares plummet as results from key trial delayed
Biopharma Dive
Puma Biotechnology
earnings
Nerlynx
clinical trials
Flag link:
MannKind Q1 Results: The Good, the Bad, and the Ugly
MannKind Q1 Results: The Good, the Bad, and the Ugly
Motley Fool
MannKind
earnings
Flag link:
bluebird bio Looks for Data Ahead
bluebird bio Looks for Data Ahead
Motley Fool
Bluebird Bio
earnings
Flag link:
Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results
Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results
Bloomberg
Mylan Labs
earnings
EpiPens
Flag link:
Novo Nordisk Fights Payer Pressure With New Meds
Novo Nordisk Fights Payer Pressure With New Meds
Motley Fool
Novo Nordisk
earnings
Flag link:
Editas Medicine Starts a "Transformative" Year on a High Note
Editas Medicine Starts a "Transformative" Year on a High Note
Motley Fool
Editas Medicine
earnings
CRISPR
Flag link:
Celgene Rises As Q1 Earnings, Sales Top Views
Celgene Rises As Q1 Earnings, Sales Top Views
Investors Business Daily
Celgene
earnings
Flag link:
Earnings Preview: What To Expect From Celgene On Friday
Earnings Preview: What To Expect From Celgene On Friday
Forbes
Celgene
earnings
Flag link:
Regeneron (REGN) Q1 Earnings Top, Sales Lag, Updates View
Regeneron (REGN) Q1 Earnings Top, Sales Lag, Updates View
Yahoo/Zacks.com
Regeneron
earnings
Flag link:
Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much
Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much
Motley Fool
Seattle Genetics
earnings
Flag link:

Pages